Friday October 5

View scientific program here (interactive) or here (pdf)

View the synoptic here

07.30 Welcoming coffee

------------------------------------------------------------------------------------

08.00 Aortic aneurysms: changes in epidemiology vs. changes in clinical practice
Janet Powell

08.15 Gender differences in AAA
Rebecka Hultgren

08.30 Pattern and associations of AAA enlargement
Frank A. Lederle

08.45 What can we learn from the non-aneurysmal infrarenal aortic diameter?
Paul Norman

09.00 Talks selected from submitted abstracts

09.00 Increased mortality in subjects with small Abdominal Aortic Aneurysm (AAA) without previous history of cardiovascular disease compared to controls is associated with increased levels of hs-CRP and H-FABP
Sohrabi Soroush

09.05 The prognosis of ruptured abdominal aortic aneurysms in Denmark 1994-2008
Jes Lindholt

09.10 Volume estimation of the aortic sac after EVAR using 3D ultrasound – a novel accurate and promising technique
Kim Kargaard Bredahl

09.15 A comparative study of abdominal aortic aneurysm (AAA) in men and women
Sohrabi Soroush

09.20 Procedures for ruptured abdominal aortic aneurysms decrease among 65-74 year old men in Sweden – but surprisingly not among the youngest
Fredrik Lundgren

09.25 Morphological scanographic analysis of infrarenal aortic aneurysms: is there any predictive rupture factor except the maximal tranverse diameter?
Jordane Herail

09.30 High Prevalence of Abdominal Aortic Aneurysm in Patients with 3-vessel
Coronary Artery Disease
Rodolphe Durieux

09.35 Discussion

09.45 Coffee break

10.15 Satellite symposium

------------------------------------------------------------------------------------

10.15 The German-Dutch-Australian AAA Expression Consortium
Jonathan Golledge

10.30 Transcriptional genomics of AAA
Gerard Tromp

10.45 LRP5 gene polymorphisms and AAA genetic susceptibility
Betti Giusti

11.00 Discussion

------------------------------------------------------------------------------------

11.10 Identification of novel biomarkers of AAA by proteomic analysis
Jose Luis Martin Ventura

11.25 Involvement of cell death in the pathophysiology of AAA
Gillian Cockerill

11.40 On the potential increase of the oxidative stress status in patients with AAA
Joel Pincemail

11.55 Role of signaling pathways in aortic aneurysms
Koichi Yoshimura

12.10 Diabetes as a protective factor for development of abdominal aortic aneurysm disease
Joost A. Van Herwaarden

12.25 Talks selected from submitted abstracts

12.25 Mechanisms for fibrinolysis of the Intraluminal Thrombus of Abdominal Aortic Aneurysm
Jesper Swedenborg

12.30 The biomarker mmp9 in open and evar patients treated for abdominal aortic aneurysm: personal experience and evidence from the literature
Andrea Ascoli Marchetti

12.35 Clotting Activation following Infra-renal Abdominal Aortic Aneurysm Intervention
Marc A Bailey

12.40 Assessment of biomarkers and predictive models for abdominal aortic aneurysm growth
Melina Vega de Céniga

12.45 Increased levels of periostin in abdominal aortic aneurysms
Osamu Yamashita

12.50 Study of the histological and biomechanical properties of fragments isolated from the anterior wall of abdominal aortic aneurysms
José Monteiro

12.55 Discussion

------------------------------------------------------------------------------------

Satellite symposium on perfusion: Tips and tricks for
a better management in aortic surgery: a team building

10.15 Welcome address
Francine Blaffart

10.20 Physiopathology of hypothermia
Filip De Somer

10.50 Surgical approach of visceral cord and cerebral protection
Marc Schepens

11.20 Monitoring of the cerebral perfusion
John Murkin

11.50 Role of fibrinogen concentrate in coagulation management
Niels Rahe Meyer

12.20 CPB and aortic surgery: the state of the art
Marc Lagny

12.50 Talks selected from submitted abstracts

12.50 Aortic surgery with circulatory arrest under tepid hypothermia
Florence De Dobbeleer

12.55 Selective cerebrospinal fluid drainage protocole is effective to prevent spinal cord ischemia during endovascular repair of thoracic aortic diseases: results of a comparative study
Philippe Amabile

13.00 Closing remarks
Filip De Somer

13.10 Lunch

14.00 Symposium
Creating standards for measuring AAA growth
Eric Allaire

14.00 Introduction
Eric Allaire

14.05 Current and future approaches with Ultrasonography
Henrik Sillesen

14.20 Current and future approaches with Computed Tomography
Timothy Baxter

14.35 AAA measuring methodology: Impact on prevalence and decision making
Anders Wanhainen

14.50 Questions & panel discussio

15.00 Special parallel satellite symposium

-------------------------------------------------------------------------------------------------

15.00 What is the best option for arch aneurysms
Furuzan Numan

15.15 Treatment of complex aortic aneurysms with fenestrated and branched grafts: technicals ins and outs results and future options
Eric Verhoeven

15.30 When is surgery suitable for thoraco-abdominal aortic aneurysms?
Michael Jacobs

15.45 Extended aortic aneurysm repair with arch replacement is feasible and safe without circulatory arrest and hypothermia
Patrice Bergeron Gianbattista Tshiombo

16.00 Discussion

16.15 Coffee break

-------------------------------------------------------------------------------------------------

16.45 Latest results of endurant registries
Hence Verhagen

16.55 Early experience with the snorkel technique for juxtarenal aneurysms
Jason Lee

17.05 The factors influencing the outcome of ruptured AAA
Apostolos Tassiopoulos

17.15 Endovascular repair of AAA: counterbalancing the benefits with the costs
Athanasios Giannoukas

17.25 Discussion

17.45 Debate and interactive discussions
- Clinical case debate: for/against
Nicos Labropoulos
- The status of EVAR for ruptured AAAs
Frank Veith
- EVAR for ruptured AAAs early results
Frank Vermassen

18.15 Talks selected from submitted abstracts

18.15 Standard aortic endograft and renal tricks for iuxtarenal landing zone. Are we bumbler voguish or real effective? Personal experience
Gilberto Boselli

18.20 Peri-operative and medium-term results of the iliac branched Z-Bis Cook Endoprothesis
Bertrand Saint-Lèbes

18.25 Long term follow-up of endograft repair of aortic transection and evolving rules of evidence for endograft repair of specific thoracic aortic pathologies
V.A. Piccone

18.30 Is there a place for the vascular prosthesis Omniflow II in the management of infected aortic reconstruction?
Sebastien Deglise

18.35 Management of Abdominal Aortic Aneurysms and concomitant cancer: the endovascular approach
Roberto Gattuso

18.40 End of the sessions

------------------------------------------------------------------------------------------

Special parallel satellite symposium: AAA Genetics
Moderators: Matt Bown & Greg Jones
------------------------------------------------------------------------------------------

15.00 Identification of the LRP1 locus in AAA
Matt Bown

15.20 Genetic studies of AAA
David Carey

15.40 Mendelian randomisation to validate causal relation-ships in AAA - IL6 as an exemplar
Daniel Swerdlow

16.00 Sequence variants in the apolipoprotein(a) gene and the risk of vascular diseases
Anna Helgadóttir

16.20 Discussion

16.30 Coffee break

17.00 Pathway directed analysis of AAA genome-wide datasets
Greg Jones

17.20 Report on AAA GWAS meta-analysis
The AAA Consortium

17.40 Follow-up of GWAS observations; determining functional and clinical relevance
The AAA Consortium

18.00 Talks selected from submitted abstracts

18.00 A novel TLR4 antagonist IAXO-102 modulates TLR4 proinflammatory signalling in the early stages of experimental aneurysm
Grisha Pirianov

18.05 Levels of endothelial nitric oxide synthase protein in different areas of ascending aortic aneurysms associated with bicuspid aortic valve can influence the cytosolic protein levels of pro-apoptotic mitochondrial serine protease HTRA2/Omi
Mohamed Salah

18.10 Sex difference in the occurrence of estrogen receptor b in the aneurysmatic aortic wall
Rebecka Hultgren

18.15 Polymorphisms in genes involved in the hypoxia-related signaling pathway increase the risk of large-artery atherosclerosis determined by smoking
Ewa Strauss

18.20 Gene expression studies reveal novel pathways in human Abdominal Aortic Aneurysm
Irene Hinterseher

18.25 Whole genome expression profiling in human ruptured abdominal aortic aneurysms
Irene Hinterseher

18.30 CXCL8 signaling pathway and the Aortic Abdominal Aneurysm (AAA): the oral CXCR2 antagonist DF2156A fully abrogates aneurysm formation
Viviane Kokje

18.35 TGF-b1-dependent upregulation of the matrix remodeling enzyme lysyl oxidaselike 4 (LOXL4) in aortic endothelial cells. Mechanism of action and contribution to aortic pathology
Fernando Rodríguez-Pascual

18.40 End of the sessions

20.00 Official dinner